Cefoselis
Cefoselis, the fourth gen-eration of cephalosporin, is a β-lactam antibiotic. Cefoselis exhibits good activity against a wide range of Gram-positive and Gram-negative organisms. Cefoselis penetrates the blood-brain barrier[1][2][3].
Product Specifications
CAS Number
122841-10-5
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefoselis.html
Solubility
10 mM in DMSO
Smiles
O=C(C(N12)=C(CN3N(CCO)C(C=C3)=N)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O
Molecular Formula
C19H22N8O6S2
Molecular Weight
522.56
References & Citations
[1]ZHU, D., et al., In vitro activities of cefoselis compared to β-lactams and other antibacterial agents aganst gram-positive and gram-negative clinical isolates. Chinese Journal of Infection and Chemotherapy, 2011. 4: p. 002.|[2]King, A., L. Bethune, and I. Phillips, The Comparative In Vitro Activity of FK-037 (Cefoselis), a New Broad-Spectrum Cephalosporin. Clin Microbiol Infect, 1995. 1 (1) : p. 13-17.|[3]K Ohtaki, et al. Cefoselis, a beta-lactam antibiotic, easily penetrates the blood-brain barrier and causes seizure independently by glutamate release. J Neural Transm (Vienna) . 2004 Dec;111 (12) :1523-35.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0009424-01 10 µg
Recombinant Matrix Metalloproteinase 28 (MMP28)
Sign In for Pricing
View Details TRV-0009424-02 50 µg
Recombinant Matrix Metalloproteinase 28 (MMP28)
Sign In for Pricing
View Details TRV-0009424-03 100 µg
Recombinant Matrix Metalloproteinase 28 (MMP28)
Sign In for Pricing
View Details